ep target maintain follow earn management express confid
abil deliv ep guidanc ep
target establish ci announc acquisit esrx
encouragingli health servic pbm segment see potenti resili
custom base anchor larg government contract depart defens
greater exposur larger corpor account addit ci expect pbm
custom retent may wind even higher given potenti less custom
disrupt pbm segment project larg unchang
result integr medic segment see volatil per
integr medic lower offset membership employ side
management note half employ taken workforc reduct action
maintain health benefit either furlough layoff benefit
continu light expect ci us commerci membership declin
y-o-i end due rise unemploy off-set management expect
benefit defer elect procedur expect defer item
come back although seemingli one-for-on may translat lower
overal util lower bp bp
unchang due view medic util normal year-end
trim ep slightli overal maintain ep estim trim
ep estim reflect lower commerci membership
next year health plan busi modest recaptur recal ci small
footprint exchang even smaller footprint medicaid capit
deploy ci indic continu conduct share repurchas
note uniqu situat given strateg divestitur group
disabl life busi expect gener bn after-tax proce
major expect use share repurchas maintain
ow rate trim pt price-to-earnings new ep estim
ci quarterli annual ep usd
lower usd
return equiti ttm
idc link barclay live interact chart
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
margin return data
overweight continu leverag
strength control medic cost continu
gain market share commerci busi
return industri growth medicar
upsid case reflect favor medic
cost trend outlook higher expect share
gain commerci medicar segment
downsid case reflect risk associ
increas cost trend aggress commerci price
lower expect commerci growth
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
pre-tax strand overhead front-end annual suppli chain initi assum increment synergi mn mn pre-tax incom guidanc y/i pre-tax incom strandedoverheadannu supplychain initiativesincrementalsynergi growth pre-tax incomeguid barclay
initi guidanceconsolid oper metricsadjust revenu adjust incom oper adjust sg expens adjust tax interest adjust margin debt capit segment oper metricshealth servic pre-tax incom adjust pharmaci billion integr medic pre-tax incom medic medic global medic custom medicar total global medic custom barclay
 consolid incom statement pharmaci invest adjust changetot expensesmed benefit medic servic excl intang oper incom loss attribut includ margin expens adjust margin tax net incom margin share fulli barclay
health servic segment pharmaci invest servic oper loss attribut expens adjust margin profit excl transit assumptionspharmaci servic cost medic invest oper loss attribut adjust margin assumptionsfe revenenu loss util subject py sg barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
